| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02041481 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2018-01-19 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 26 | |
| P4844 | research intervention | leucovorin calcium | Q27077063 |
| fluorouracil | Q238512 | ||
| calcium oxalate | Q412399 | ||
| P580 | start time | 2014-06-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Phase I Clinical Trial of MEK162 in Combination With FOLFOX in Patients With Advanced Metastatic Colorectal Cancer Who Failed Prior Standard Therapy |
Search more.